G'day all,
Excited by this announcement, will be along for the ride to see how it pans out.
I haven't digested all of the above comments, but what has sprung to mind for me is the following.
Will IHL continue to receive the 42.5% R+D rebate for research conducted in Australia if the parent company of the trial is no longer domiciled in Australia?
- Forums
- ASX - By Stock
- IHL
- Ann: IHL Intends to Redomicile to US & List all Shares on Nasdaq
Ann: IHL Intends to Redomicile to US & List all Shares on Nasdaq, page-115
-
- There are more pages in this discussion • 441 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)